Cleared Special

K031718 - LIFEVALVE CENTRAL VENOUS CATHTER

K031718 is an FDA 510(k) clearance for LIFEVALVE CENTRAL VENOUS CATHTER, manufactured by Horizon Medical Products, Inc.. The device is a Class 2 General Hospital device with product code LJS cleared through the Special 510(k) pathway after a 29-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2003
Decision
29d
Days
Class 2
Risk

K031718 is an FDA 510(k) clearance for the LIFEVALVE CENTRAL VENOUS CATHTER. Classified as Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days (product code LJS), Class II - Special Controls.

Submitted by Horizon Medical Products, Inc. (Manchester, US). The FDA issued a Cleared decision on July 2, 2003 after a review of 29 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5970 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Horizon Medical Products, Inc. devices

FDA 510(k) Submission Details - K031718

510(k) Number K031718 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 03, 2003
Decision Date July 02, 2003
Days to Decision 29 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
100d faster than avg
Panel avg: 129d · This submission: 29d
Pathway characteristics
Modification to existing cleared device.

LJS Device Classification - Class 2, Special Controls

Product Code LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5970
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days

All 191
Devices cleared under the same product code (LJS) and FDA review panel - the closest regulatory comparables to K031718.
ANGIODYNAMICS, INC. MORPHEUS PICC AND PROCEDURE KIT
K040446 · AngioDynamics, Inc. · Mar 2004
POLY PER-Q-CATH PICC CATHETERS
K034019 · C.R. Bard, Inc. · Jan 2004
GROSHONG NXT PICC CATHETERS
K034020 · C.R. Bard, Inc. · Jan 2004
ANGIODYNAMICS, INC. MORPHEUS PICC AND PROCEDURE KIT
K031626 · AngioDynamics, Inc. · Jun 2003
POLY PER-Q-CATH PICC CATHETERS
K031129 · C.R. Bard, Inc. · May 2003
ANGIODYNAMICS, INC. MORPHEUS PICC AND PROCEDURE KIT
K030415 · AngioDynamics, Inc. · Apr 2003